Efstathios Kastritis1, Meletios Dimopoulos. Show Affiliations » 1. Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antineoplastic Agents/adverse effectsHeparin, Low-Molecular-Weight/therapeutic useHumansLenalidomideMultiple Myeloma/drug therapyThalidomide/adverse effectsThalidomide/analogs & derivativesVenous Thrombosis/prevention & control
Substances: See more » Antineoplastic AgentsHeparin, Low-Molecular-WeightThalidomideLenalidomide
Year: 2007 PMID: 18066998 DOI: 10.1080/10428190701742530
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022